Conestoga Capital Advisors' Q2 2024 investor letter discusses the moderation in economic indicators, impacting equity markets. Their Micro-Cap Strategy underperformed due to negative stock selection effects. Mesa Laboratories, Inc. was highlighted as a promising investment despite not being among the top holdings.